5.Immune 2 study guide
I. Distinguishing Self from Nonself
Self-Tolerance: The absence of an immune response against a person's own antigens.
Maintained through several mechanisms, including:
Major Histocompatibility Complex (MHC) molecules on cell surfaces.
Role of MHC: Display antigens for T cell inspection.
Types of MHC Molecules:
Class I MHC molecules:
Found on nearly all nucleated cell membranes (not phagocytic cells).
Present intracellular antigens:
Normal "self" antigens.
Viruses (gained access to cells).
Abnormal cell proteins (due to mutations).
Interact with cytotoxic T cells; T cells recognize antigens complexed to Class I MHC.
Class II MHC molecules:
Found mainly on macrophages/apc (phagocytic cells).
Present extracellular antigens.
Interact with helper T cells; T cells recognize antigens complexed to Class II MHC.
Lack of display on Class II MHC → no activation of helper T cells.
II. Inflammation
Description: Tissue reaction to injury, regardless of the cause.
Purpose: Initiate healing by:
Neutralizing/destroying harmful agents.
Limiting their spread.
Preparing damaged tissue for repair (removing dead tissue, nutrient transport).
Signs & Symptoms (Cardinal Signs):
Redness
Heat
Swelling
Pain
Impaired function
Mechanism of Action: Involves release of chemical mediators:
Chemical Mediators: Histamine, prostaglandins, leukotrienes, plasma proteases, platelet-activating factor, cytokines.
Vascular Response:
Initial vasoconstriction, followed by vasodilation.
Increased capillary permeability leads to fluid escape into tissues.
Cellular Response:
Movement of WBCs into the injured area.
Acute-Phase Response: Systemic effects due to cytokine release:
Fever.
Increased WBC counts.
Skeletal muscle catabolism.
III. Potential Problems Related to Inflammation
Issues with Compromised Immune Function:
Breakdown in self-tolerance.
Pathological changes possible due to immune dysfunction.
Inflammation can cause further tissue damage.
IV. Normal Physiology of the Immune System
Functions:
Provide immunity.
Distinguish self from nonself.
Mediate inflammation.
Cancer surveillance.
Self-Tolerance Maintenance:
Mediated by suppressor T cells, elimination of self-reactive immune cells, and requirement of foreign antigens to activate T cells through MHC molecules.
V. Pathological Changes/Predisposing Factors**
Pathological Changes:
Breakdown in immune self-tolerance can occur due to:
Abnormality in self-antigen structure.
Faulty T cell receptor/MHC interaction.
Disorders of immune surveillance.
Antigenic mimicry (similarities between foreign and self-antigens).
Release of sequestered antigens (self-antigens released post-injury).
Predisposing Factors (PF):
Genetic factors.
Trigger events (viruses, chemicals, stressors).
Gender/hormones (more common in women).
VI. Example of an Autoimmune Disorder: Systemic Lupus Erythematosus
Pathophysiology: Development of antibodies against self-antigens (e.g., nuclear antigens).
Cell damage releases DNA, which forms anti-DNA antibodies.
Antibody complexes deposit in tissues, activating the complement system.
Results in inflammation and further cellular damage (vicious cycle).
VII. Inflammatory Response**
Tissue Injury: Leads to:
Release of chemical mediators (histamine, prostaglandins, etc.).
Vascular response: Vasodilation, increased capillary permeability.
Cellular response: Movement of WBCs and systemic effects (fever, increased WBCs).
Resulting in cardinal signs: Redness, heat, swelling, pain, impaired function.
VIII. Hypersensitivity Disorders**
Pathological Response: Immune response to antigens that typically do not affect others.
Classifications:
Type I (IgE-mediated): Allergens bind to IgE → mediator release.
Type II (Cytotoxic): IgG/IgM interact with cell/tissue antigens → cell damage.
Type III (Immune complex-mediated): Antigen-antibody complexes cause inflammation/damage.
Type IV (T cell-mediated): T cell-induced tissue damage.
Potential Nursing Problems:
Examples:
Type I: Allergic rhinitis, asthma, anaphylaxis.
Type II: Blood transfusion reactions.
Type III: Systemic lupus erythematosus (SLE).
Type IV: Contact dermatitis.
IX. Assessment Findings**
Specific to individual disorders as clinical manifestations of the various hypersensitivity reactions.